Triple negative breast cancer

Chair: Adrian Harris, University of Oxford, UK
Speaker: Jean Abraham, University of Cambridge, UK
Speaker: Roger Daly, Monash University, Australia
Speaker: Peter Schmid, Barts Cancer Institute, UK


Room: Dochart

The session will focus on triple negative breast cancer (TNBC), with speakers discussing the basic biology, recent translational work and clinical trials in this cancer subtype. Participants will gain a broad exposure to the fundamental mechanisms driving TNBC and some of the recent clinical applications of these discoveries. In particular, there will be a focus on recent clinical trial data in TNBC.